The US launch of a myopia control spectacle lens, research into modifiable myopia risk factors, and atropine developments ...

Santen today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ryjunea® (low-dose atropine 0.1 mg/ml), the first licensed treatment in the UK to slow the ...

Sydnexis, Inc., ( a biopharmaceutical company focused on pediatric progressive myopia (PPM), today announced topline results from the Phase 3 STAR trial of SYD-101, a proprietary 0.01% atropine ...

Over time, as the Bush administration sank into ignominy, Cheney’s influence waned. He left office one of its most reviled ...

Adthena, the market-leading AI-driven search intelligence platform, has announced it has been recognized by Google as a Trusted Trademark Partner, a status that signals a high level of expertise with ...

Initiated full U.S. commercial launch of AYON Body Contouring System™ (AYON) at end of Q3 2025, with demand for pre-orders exceeding expectationsSubmitted new 510(k) for AYON for device label ...

So on that I'm going to end today and next time we will talk about justice, the philosophers and Plato's discovery of America ...